Migraine. One of the most common epidemics of the century.
It has been scientists' agenda for many years to work to put even a strong headache in people from social life. The solution, however, is that this day of widespread pain and increased violence can not be found to be interesting.
According to a study published Thursday on the New England Health website, which combats migraine problems, people experience severe headaches for 3-4 days each month. On the other hand, when 1,000 volunteers participated as a drug called Erenumab, the experienced migraine was reduced.
Every 7 adult migraine headaches seen on an individual basis is an important public health problem that, on average, creates millions of unnecessary Mar shots and medical interventions each year.
How does Erenumab do his medical profession?
First, let's talk about how the medicine works. For this, it would be useful to know the concept of the placebo effect: placebo effect is a pharmacologically ineffective drug that produces an adhesive-based effect. In other words, this effect comes from the idea that a completely dysfunctional medicine works psychologically.
In drug trials with Erenumab, participants were told to use the disease for six months. Patients in the other group received fake medications that would create a placebo effect. Approximately 43% of these patients in the first six months were treated with 70 milligrams of erenumab per month. In true diseased people, migraine attacks have been observed to decrease by about 50%. Only one of the four participants with placebo had the same painless day.
The Pharmaceutical Institute in the United States is expected to be released by a medical and FDA-approved graduation. In short, a medical solution has been found for migraine and the effects are scientifically proven. After the bureaucratic process, drug shelves may need to be completed.
No comments